Boardroom Alpha
Boardroom Alpha
GNSS · Current Report (Form 8-K) · Filed March 18, 2026

Genasys Inc — Current Report (Form 8-K)

Form
8-K
Filed
March 18, 2026
Period
Mar 17, 2026
Ticker
GNSS
Accession
0001193125-26-114015
Boardroom Alpha · Filing insights

Five director nominees elected; Baker Tilly US, LLP ratified as auditor; executive compensation approved on advisory basis.

About Genasys Inc
Market cap
$76M
1Y TSR
−2.1%
3Y TSR
−18.1%
Board grade
B+
Sector
Technology
Last annual meeting: Mar 17, 2026 · View full Genasys Inc profile →
8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 17, 2026

 

 

Genasys Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

000-24248

87-0361799

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

16262 West Bernardo Drive

 

San Diego, California

 

92127

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 858 676-1112

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common stock, $0.00001 par value per share

 

GNSS

 

NASDAQ Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

Genasys Inc. (the “Company”) held its Annual Meeting of Stockholders (the “2026 Annual Meeting”) on March 17, 2026. The number of shares of the Company’s common stock outstanding and eligible to vote as of January 21, 2026, the record date for the 2026 Annual Meeting, was 45,212,311. Of these, a total of 25,083,917 shares were voted, either in person or by proxy. The following is a brief description of each matter voted upon at the 2026 Annual Meeting, as well as the number of votes cast for, against or withheld as to each matter, and, if applicable, the number of abstentions and broker non-votes:

 

Election of Directors:

 

The five individuals listed below were elected at the 2026 Annual Meeting to serve for a one-year term on the Company’s Board of Directors (the “Board”):

 

Nominee

 

Number of Shares
Voted For

 

Number of Shares
Withheld

 

Broker Non-Votes

 

Richard S. Danforth

 

 

13,145,959

 

 

2,224,572

 

 

9,713,386

 

William H. Dodd

 

 

13,965,420

 

 

1,405,111

 

 

9,713,386

 

W. Craig Fugate

 

 

13,879,560

 

 

1,490,971

 

 

9,713,386

 

R. Rimmy Malhotra

 

 

13,916,633

 

 

1,453,898

 

 

9,713,386

 

Susan Lee Schmeiser

 

 

11,326,368

 

 

4,044,163

 

 

9,713,386

 

 

Ratification of Independent Registered Public Accounting Firm:

 

The ratification of the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2026, was approved by the following votes:

 

For

 

 

Against

 

Abstain

 

 

21,419,235

 

 

 

2,005,498

 

 

1,659,184

 

 

Advisory Vote on the Compensation of the Company’s Named Executive Officers:

 

The compensation of the Company’s named executive officers as described in its proxy statement filed with the Securities and Exchange Commission on January 28, 2026 (the “Proxy Statement”), was approved, on an advisory, non-binding basis, by the following votes:

 

For

 

 

Against

 

Abstain

 

Broker Non-Votes

 

 

8,844,760

 

 

 

5,107,733

 

 

1,418,038

 

 

9,713,386

 

 

As a result of the 2026 Annual Meeting, all five director nominees were elected to the Board, Baker Tilly US, LLP’s appointment as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2026 was ratified and the compensation of the Company’s named executive officers as described in the Proxy Statement was approved on an advisory, non-binding basis.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Genasys Inc.

 

 

 

 

Date:

March 18, 2026

By:

/s/ Cassandra L. Hernandez-Monteon

 

 

 

Cassandra L. Hernandez-Monteon
Chief Financial Officer

 


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Genasys Inc (GNSS)

Reference

Frequently asked questions

When did Genasys Inc file this 8-K?
Genasys Inc (GNSS) filed this Current Report (Form 8-K) with the SEC on March 18, 2026. The accession number assigned by EDGAR is 0001193125-26-114015.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Five director nominees elected; Baker Tilly US, LLP ratified as auditor; executive compensation approved on advisory basis. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Genasys Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Genasys Inc has filed under CIK 924383, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer